The EBMT (UK) NAP Committee welcomes you. As part of the main EBMT group we exist to provide education and networking opportunities for all healthcare professionals involved in the care of stem cell transplant patients in the UK.

We meet once a year but have now developed this site to give opportunities to network outside of the meetings. Please take a moment to register so that you receive regular updates and information about our meetings. As more details become available on the forthcoming meeting you will be able to register through this site.
Please register for membership of the site as it will be great to start sharing ideas.

Revised diagnosis and severity criteria for SOS/VOD

This report marks an important development in the management of SOS/VOD that aims to allow early detection, with the goal of earlier treatment and improved outcomes, abstract below and full article in the learning section


Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life threatening complication that can develop after hematopoietic cell transplantation. Although SOS/VOD progressively resolves within a few weeks in most patients, the most severe forms result in multi-organ dysfunction and are associated with a high mortality rate (40%). There fore, careful attention must be paid to allow an early detection of SOS/VOD, particularly as drugs have now proven to be effective and licenced for its treatment. Unfortunately, current criteria lack sensitivity and specificity, making early identification and severity assessment of SOS/VOD difficult. The aim of this work is to propose a new definition for diagnosis, and a severity grading system for SOS/VOD in adult patients, on behalf of the European Society for Blood and Marrow Transplantation.

Bone Marrow Transplantation (2016) 51, 906912; doi:10.1038/bmt.2016.130; published online 16 May 2016